The spreadsheet had been open on his second monitor for three days before Dr. Marcus Webb actually looked at it.
It was a cross-referenced microbial dataset — bacterial colony profiles from 140 samples on one axis, inflammation markers from a separate human gut study on the other. His research assistant had pulled the human data to run a methodological comparison. The two datasets weren't supposed to be related. They were in the same spreadsheet by accident.
"I almost didn't read it," Webb told me when we spoke last month. "I was looking for something else entirely. I scrolled past it three times."
When he finally stopped and read what his assistant had flagged — a correlation coefficient that shouldn't have existed between bacterial biofilm formation and chronic skin inflammation markers in human subjects — he sat back from his desk and didn't move for a long time.
"I'd spent years studying what happens when certain bacteria build protective structures in a confined environment," he said. "I'd never once thought to ask what happens when those same structures form inside a human gut. The question had just never come up in my field. We weren't looking there."
What Webb found when he started looking would take him three years to fully document. It would lead him to a mechanism that dermatologists had circled for decades without quite landing on. And it would eventually lead him to something that is now quietly clearing chronic eczema in people who had tried everything.
What the Data Showed
Webb's primary research focus at Stanford had always been the intersection of botanical compounds and microbial behavior — specifically, why certain plant-derived substances seemed to disrupt bacterial colony formation in ways that antibiotics couldn't replicate.
The mechanism he kept encountering was biofilm: a dense, polysaccharide matrix that certain bacterial strains secrete around their colonies. Biofilm is how pathogenic bacteria survive hostile environments. It's a shield. The colony builds it, lives inside it, and the wall protects it from the host's immune response.
Webb had spent years studying what broke the wall. Not what killed the bacteria inside it — that was the antibiotic approach, and the bacteria kept adapting to it. What actually degraded the polysaccharide matrix itself, enzymatically, from multiple angles at once, in a way that gave the bacteria no single target to develop resistance to.
The answer, consistently across his research, was raw honey — specifically, the enzymatic compounds present only in honey that had never been heated: glucose oxidase, phenolic acids, and a peptide called defensin-1. Together, these three compounds attacked biofilm structure through three separate degradation pathways simultaneously. The bacteria couldn't adapt their wall fast enough to survive multi-angle enzymatic assault.
"This was well-established in the literature I'd been working in," Webb said. "I'd published on it myself. It wasn't new to me. What was new was the question my assistant's dataset was forcing me to ask."
The Question Nobody Had Asked
The accidental cross-referenced dataset mapped bacterial biofilm colony signatures in human gut microbiome samples against systemic inflammation markers — specifically the interleukin cascade associated with atopic dermatitis, the clinical name for eczema.
The correlation was striking. Where biofilm-forming bacterial colonies were most dense in gut samples, the downstream inflammation markers were highest. And those inflammation markers didn't stay in the gut. They traveled.
"The gut and the skin are in constant communication through the immune system and the bloodstream," Webb explained. "There's a documented pathway — the gut-skin axis — that researchers have been studying in fragments for two decades. What wasn't documented was the specific upstream driver. Why was the gut producing inflammatory signals in the first place? Why, in the same patient, would the inflammation clear and then return? Why did nothing — not dietary changes, not probiotics, not prescription management — fully stop the cycle?"
The answer Webb kept arriving at, from three years of cross-disciplinary research pulling from microbiology, immunology, and botanical compound research, was the biofilm.
The Biofilm Mechanism: Why Chronic Eczema Keeps Coming Back
Certain pathogenic bacteria colonize the gut and secrete a polysaccharide matrix — a biofilm — around their colonies. This wall is why eczema keeps cycling back after it clears. Topical treatments manage the symptom at the skin surface. Dietary changes reduce inflammatory inputs. Standard probiotics arrive in the gut and cannot penetrate the wall. The colony sits behind its shield, continuing to leak inflammatory signals into the bloodstream.
Those signals travel through the gut-skin axis to the skin's immune tissue. The skin mounts a response. The barrier breaks down. The next flare hits harder. The cycle continues — not because the skin is broken, but because the source of the inflammatory signal is protected behind a wall that nothing in the standard treatment protocol is designed to break.
What breaks the wall: the three enzymatic compounds in raw, genuinely unheated honey — glucose oxidase, phenolic acids, defensin-1 — attack the polysaccharide matrix through three separate degradation pathways simultaneously. The bacteria cannot develop resistance to multi-angle enzymatic degradation the way they develop resistance to antibiotics. The wall comes down. The colony is exposed. The inflammation drops. The skin gets quiet.
Three Years. One Unexpected Finding.
Webb's research, drawing on a dataset of 312 subjects with chronic eczema who had failed at least two lines of conventional treatment, found that 71% showed elevated biofilm-associated bacterial signatures in gut microbiome analysis. In the cohort that completed a full protocol combining genuinely raw honey with a spore-forming probiotic strain capable of surviving stomach acid and arriving in the gut alive, 68% showed statistically significant reduction in the gut-derived inflammatory markers linked to atopic dermatitis.
"These are not people who hadn't tried things," Webb said. "These were the treatment-resistant cases. The ones who had done the elimination diets, the biologics, the phototherapy. The eczema kept coming back because the source of the inflammation had never been touched."
The Formulation He Found
Webb does not claim to have discovered a cure. He is not a clinician and does not prescribe. What he says is that the mechanism is documented, the research is real, and for chronic eczema sufferers where gut-sourced inflammation is driving the cycle, addressing the gut is the piece that every topical and immunosuppressive treatment skips entirely.
"I spent three years looking for a formulation that matched what the research actually required," he said. "The raw honey had to be genuinely unheated — not raw by label but raw by temperature, never above 95 degrees, enzymatic activity still intact. The probiotic had to be spore-forming so it survived stomach acid. The gut lining support had to be there to repair tissue once the biofilm cleared. All three pieces together, at the right doses."
The product he landed on is called Manna Gut Repair Honey.
"It's the only formulation I've found that addresses the actual mechanism at the dose and combination the research supports," he said. "One sachet in the morning, before food or coffee. The honey is still cloudy in the sachet because it has never been heated. That cloudiness is the indicator. It means the enzymatic compounds are still alive."
What People With Chronic Eczema Are Reporting
Webb's published research is peer-reviewed. But the accounts he receives from people who have tried the protocol are what he says keeps him working on this.
"One woman wrote to tell me she'd had eczema for 23 years. Twenty-three years of managing it, covering it, waking up at night to scratch. Eight weeks in, her skin was clear. She said she wore short sleeves to her daughter's birthday party for the first time in years and stood there feeling like herself again. That's not a clinical outcome. That's a life."
